Literature DB >> 455293

Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.

J D Moyer, R E Handschumacher.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455293

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  12 in total

Review 1.  Applications of magnetic resonance in model systems: cancer therapeutics.

Authors:  J L Evelhoch; R J Gillies; G S Karczmar; J A Koutcher; R J Maxwell; O Nalcioglu; N Raghunand; S M Ronen; B D Ross; H M Swartz
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).

Authors:  G J Peters; S L Sharma; E Laurensse; H M Pinedo
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

3.  Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.

Authors:  A Zeevi; G Z Yao; R Venkataramanan; R J Duquesnoy; S Todo; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

4.  Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth.

Authors:  A Forsgren; A Bredberg; A B Pardee; S F Schlossman; T F Tedder
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

5.  Modulation of 5-FU metabolism in human MCF-7 breast carcinoma cells.

Authors:  P P Major; E M Egan; L Sargent; D W Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer.

Authors:  E Rosvold; R Schilder; J Walczak; S M DiFino; P J Flynn; T K Banerjee; W J Heim; P F Engstrom; R F Ozols; P J O'Dwyer
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.

Authors:  K Bhalla; S Grant
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.

Authors:  G J Peters; C J van Groeningen; E J Laurensse; J Lankelma; A Leyva; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation.

Authors:  S Spiegelman; R Sawyer; R Nayak; E Ritzi; R Stolfi; D Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  Phase-I trial of combination therapy with continuous-infusion MMPR and continuous-infusion 5-FU.

Authors:  W P Peters; G Weiss; D W Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.